November 9 2020

November 9, 2020—IPM welcomes today’s news that an injection of the antiretroviral drug cabotegravir administered every two months was found to be well-tolerated and highly effective in reducing... More »

September 26 2020

On World Contraception Day, we are reminded that many women around the world still lack the range of tools they need to prevent HIV and unintended pregnancy, and protect their sexual and reproductive... More »

July 24 2020

IPM’s Dapivirine Ring Could Give Women in Sub-Saharan Africa First Long-Acting HIV Prevention Option; Opinion Paves Way for WHO and National Regulatory Reviews SILVER SPRING, Md. (July 24, 2020)—The... More »

July 24 2020

Read this visual story on IPM's monthly dapivirine ring, the first long-acting HIV prevention product that recently achieved a milestone in women's HIV prevention.... More »

June 5 2020

June 5, 2020—Over the past few months, we have found our lives disrupted by the novel coronavirus. Now we are confronting a much older and more insidious horror as we grapple with the deaths of... More »